Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v4-FR
Language English French
Date Updated 2020-01-28 2020-01-28
Drug Identification Number 02469170 02469170
Brand name LUPIN-CEPHALEXIN LUPIN-CEPHALEXIN
Common or Proper name LUPIN-CEPHALEXIN LUPIN-CEPHALEXIN
Company Name LUPIN PHARMA CANADA LIMITED LUPIN PHARMA CANADA LIMITED
Ingredients CEPHALEXIN CEPHALEXIN
Strength(s) 125MG 125MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 150 ML 150 ML
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-28 2020-01-28
Estimated end date 2020-02-28 2020-02-28
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments n.a processing tests
Health Canada comments